Yvonne L. Greenstreet

2017

In 2017, Yvonne L. Greenstreet earned a total compensation of $984.7K as Executive Vice President, Chief Operating Officer at Alnylam Pharmaceuticals, a 84% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$327,730
Salary$504,200
Other$152,744
Total$984,674

Greenstreet received $504.2K in salary, accounting for 51% of the total pay in 2017.

Greenstreet also received $327.7K in non-equity incentive plan and $152.7K in other compensation.

Rankings

In 2017, Yvonne L. Greenstreet's compensation ranked 9,050th out of 14,666 executives tracked by ExecPay. In other words, Greenstreet earned more than 38.3% of executives.

ClassificationRankingPercentile
All
9,050
out of 14,666
38th
Division
Manufacturing
3,459
out of 5,768
40th
Major group
Chemicals And Allied Products
1,185
out of 2,074
43rd
Industry group
Drugs
948
out of 1,730
45th
Industry
Pharmaceutical Preparations
741
out of 1,329
44th
Source: SEC filing on March 23, 2018.

Greenstreet's colleagues

We found six more compensation records of executives who worked with Yvonne L. Greenstreet at Alnylam Pharmaceuticals in 2017.

2017

Manmeet Soni

Alnylam Pharmaceuticals

Chief Financial Officer

2017

John Maraganore

Alnylam Pharmaceuticals

Chief Executive Officer

2017

Barry Greene

Alnylam Pharmaceuticals

President

2017

Akshay Vaishnaw

Alnylam Pharmaceuticals

President, Research and Development

2017

Michael Mason

Alnylam Pharmaceuticals

Vice President of Finance and Treasurer former principal financial officer

2017

David-Alexandre Gros

Alnylam Pharmaceuticals

Former Senior Vice President, Chief Business Officer former principal financial officer

News

You may also like